AtaiBeckley (ATAI) Return on Capital Employed (2021 - 2025)
AtaiBeckley (ATAI) reported Return on Capital Employed of 187.28% for Q1 2025, down 14359.0% on a YoY basis from N/an in Q1 2024, and down 282.03% sequentially from 49.02% in Q2 2024.
AtaiBeckley (ATAI) Return on Capital Employed (2021 - 2025) Analysis & Trends
AtaiBeckley (ATAI) has 5 years of Return on Capital Employed data on file, last reported at 187.28% in Q1 2025.
- For the quarter ending Q1 2025, Return on Capital Employed fell 14359.0% year-over-year to 187.28%; the trailing twelve-month figure through Mar 2025 stood at 187.28% (down 14359.0% YoY), and the FY2024 full-year result was 50.97%, down 605.0% from the prior year.
- Return on Capital Employed slipped to 187.28% in Q1 2025, from 49.02% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 1232.45% in Q3 2021 to a low of 187.28% in Q1 2025.
- A 5-year average of 235.72% and a median of 47.61% in 2022 frame the typical range for Return on Capital Employed.
- Across the five-year window, Return on Capital Employed plunged 79741 bps in 2022 and jumped 924 bps in 2024, its largest moves.
- Tracing ATAI's Return on Capital Employed over 5 years: stood at 749.81% in 2021, then tumbled by 106 bps to 47.61% in 2022, then grew by 6 bps to 44.69% in 2023, then retreated by 10 bps to 49.02% in 2024, then tumbled by 282 bps to 187.28% in 2025.
- Business Quant data shows ATAI's Return on Capital Employed at 187.28% in Q1 2025, 49.02% in Q2 2024, and 43.69% in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -31.80% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.46% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -68.47% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 21.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 10.19% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -68.84% |
| 10 | AtaiBeckley | 2.56 Bn | 2.56 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -187.28% |
| Jun 30, 2024 | -49.02% |
| Mar 31, 2024 | -43.69% |
| Dec 31, 2023 | -44.69% |
| Sep 30, 2023 | -49.57% |
| Jun 30, 2023 | -56.60% |
| Mar 31, 2023 | -52.93% |
| Dec 31, 2022 | -47.61% |
| Dec 31, 2021 | 749.81% |
| Sep 30, 2021 | 1,232.45% |
| Jun 30, 2021 | 1,142.05% |